{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:34Z","timestamp":1787028634205,"version":"build-2736575974"},"reference-count":69,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIDCD","award":["U24-DC020857"],"award-info":[{"award-number":["U24-DC020857"]}]},{"name":"Larry Bowman","award":["U24-DC020857"],"award-info":[{"award-number":["U24-DC020857"]}]},{"name":"Remondi Foundation","award":["U24-DC020857"],"award-info":[{"award-number":["U24-DC020857"]}]},{"name":"Bertarelli Foundation Endowed Professorship (KMS)","award":["U24-DC020857"],"award-info":[{"award-number":["U24-DC020857"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Spiral ganglion neurons (SGNs) connect cochlear hair cells with higher auditory pathways and their degeneration due to drug toxicity (ototoxicity) contributes to hearing loss. This study aimed to identify drug classes that are negatively correlated with the transcriptome of regenerating SGNs. Human orthologs of differentially expressed genes within the regenerating neonatal mouse SGN transcriptome were entered into CMap and the LINCS unified environment and perturbation-driven gene expression was analyzed. The CMap connectivity scores ranged from 100 (positive correlation) to \u2212100 (negative correlation). Insulin-like growth factor 1\/receptor (IGF-1\/R) inhibitors were highly negatively correlated with the regenerating SGN transcriptome (connectivity score: \u221298.87). A systematic literature review of clinical trials and observational studies reporting otologic adverse events (AEs) with IGF-1\/R inhibitors identified 108 reports (6141 treated patients). Overall, 16.9% of the treated patients experienced any otologic AE; the rate was highest for teprotumumab (42.9%). In a meta-analysis of two randomized placebo-controlled trials of teprotumumab, there was a significantly higher risk of hearing-related (pooled Peto OR [95% CI]: 7.95 [1.57, 40.17]) and of any otologic AEs (3.56 [1.35, 9.43]) with teprotumumab vs. a placebo, whether or not dizziness\/vertigo AEs were included. These results call for close audiological monitoring during IGF-1-targeted treatment, with prompt referral to an otolaryngologist should otologic AEs develop.<\/jats:p>","DOI":"10.3390\/jcm12103485","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:58:06Z","timestamp":1684288686000},"page":"3485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential Ototoxicity of Insulin-like Growth Factor 1 Receptor Signaling Inhibitors: An In Silico Drug Repurposing Study of the Regenerating Cochlear Neuron Transcriptome"],"prefix":"10.3390","volume":"12","author":[{"given":"Lino E.","family":"Bertagnoli","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA"},{"name":"Paracelsus Medical University, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Seist","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA"},{"name":"Paracelsus Medical University, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Batts","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina M.","family":"Stankovic","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA"},{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA"},{"name":"Wu Tsai Neuroscience Institute, Stanford University, Stanford, CA 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zetes, D.E., Tolomeo, J.A., and Holley, M.C. (2012). Structure and mechanics of supporting cells in the guinea pig organ of Corti. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049338"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nature03418","article-title":"Hair cell synaptic ribbons are essential for synchronous auditory signalling","volume":"434","author":"Khimich","year":"2005","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0959-4388(03)00098-9","article-title":"The afferent synapse of cochlear hair cells","volume":"13","author":"Fuchs","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7874\/jao.2017.00360","article-title":"Ototoxicity: A challenge in diagnosis and treatment","volume":"22","author":"Ganesan","year":"2018","journal-title":"J. Audiol. Otol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: Mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Parfitt","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5002434","article-title":"Ototoxicity","volume":"72","author":"Rybak","year":"2007","journal-title":"Kidney Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.heares.2012.12.014","article-title":"A brief history of hair cell regeneration research and speculations on the future","volume":"297","author":"Rubel","year":"2013","journal-title":"Hear. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1387\/ijdb.072408js","article-title":"Hair cell regeneration in the avian auditory epithelium","volume":"51","author":"Stone","year":"2007","journal-title":"Int. J. Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"829564","DOI":"10.3389\/fnmol.2021.829564","article-title":"Regulation of spiral ganglion neuron regeneration as a therapeutic strategy in sensorineural hearing loss","volume":"14","author":"Wang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0194599813518876","article-title":"Heptanol application to the mouse round window: A model for studying cochlear lateral wall regeneration","volume":"150","author":"Stevens","year":"2014","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fphar.2014.00198","article-title":"Spontaneous recovery of cochlear fibrocytes after severe degeneration caused by acute energy failure","volume":"5","author":"Mizutari","year":"2014","journal-title":"Front. Pharmacol."},{"key":"ref_12","first-page":"67","article-title":"Synaptic regeneration and functional recovery after excitotoxic injury in the guinea pig cochlea","volume":"318","author":"Puel","year":"1995","journal-title":"Comptes Rendus Acad. Sci. III"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"684706","DOI":"10.3389\/fncel.2021.684706","article-title":"Cochlear synaptic degeneration and regeneration after noise: Effects of age and neuronal subgroup","volume":"15","author":"Hickman","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wu, C.C., Brugeaud, A., Seist, R., Lin, H.C., Yeh, W.H., Petrillo, M., Coppola, G., Edge, A.S.B., and Stankovic, K.M. (2020). Altered expression of genes regulating inflammation and synaptogenesis during regrowth of afferent neurons to cochlear hair cells. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238578"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"571155","DOI":"10.3389\/fncel.2020.571155","article-title":"Insulin-like growth factor 1 on the maintenance of ribbon synapses in mouse cochlear explant cultures","volume":"14","author":"Gao","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fnagi.2017.00411","article-title":"The role of insulin-like growth factor 1 in the progression of age-related hearing loss","volume":"9","author":"Lassaletta","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/dneu.20336","article-title":"Survival, synaptogenesis, and regeneration of adult mouse spiral ganglion neurons in vitro","volume":"67","author":"Wei","year":"2007","journal-title":"Dev. Neurobiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/01945998221094457","article-title":"Ototoxicity review: A growing number of non-platinum-based chemo- and immunotherapies","volume":"168","author":"Naples","year":"2022","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_19","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: A reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/17460441.2011.562887","article-title":"The design and screening of drugs to prevent acquired sensorineural hearing loss","volume":"6","author":"Mukherjea","year":"2011","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2022.02.015","article-title":"Hearing dysfunction after treatment with teprotumumab for thyroid eye disease","volume":"240","author":"Sears","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/mp.54.5.311","article-title":"Insulin-like growth factor 1 (IGF-1): A growth hormone","volume":"54","author":"Laron","year":"2001","journal-title":"Mol. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-020-00904-3","article-title":"Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: A challenge for cancer therapy","volume":"13","author":"Hua","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semcancer.2016.08.007","article-title":"ALK alterations and inhibition in lung cancer","volume":"42","author":"Le","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"ref_25","unstructured":"United States Food and Drug Administration (2023, February 23). Highlights of Prescribing Information: ZYKADIA, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/205755lbl.pdf."},{"key":"ref_26","unstructured":"United States Food and Drug Administration (2023, February 23). Highlights of Prescribing Information: TEPEZZA, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761143s000lbl.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/IOP.0000000000001995","article-title":"Teprotumumab and hearing loss: Case series and proposal for audiologic monitoring","volume":"38","author":"Belinsky","year":"2022","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1097\/MAO.0000000000003428","article-title":"Sensorineural hearing loss after teprotumumab therapy for thyroid eye disease: A case report","volume":"43","author":"Ding","year":"2022","journal-title":"Otol. Neurotol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mato, \u00c1., Cervantes, B., Murillo-Cuesta, S., Rodr\u00edguez-de la Rosa, L., and Varela-Nieto, I. (2021). Insulin-like growth factor 1 signaling in mammalian hearing. Genes, 12.","DOI":"10.3390\/genes12101553"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Celaya, A.M., Rodr\u00edguez-de la Rosa, L., Berm\u00fadez-Mu\u00f1oz, J.M., Zubeldia, J.M., Rom\u00e1-Mateo, C., Avenda\u00f1o, C., Pallard\u00f3, F.V., and Varela-Nieto, I. (2021). IGF-1 haploinsufficiency causes age-related chronic cochlear inflammation and increases noise-induced hearing loss. Cells, 10.","DOI":"10.3390\/cells10071686"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.exger.2006.10.014","article-title":"Age-related hearing loss in CD\/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea","volume":"42","author":"Riva","year":"2007","journal-title":"Exp. Gerontol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/jmg.40.12.913","article-title":"A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency","volume":"40","author":"Bonapace","year":"2003","journal-title":"J. Med. Genet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/jc.2004-1254","article-title":"Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation","volume":"90","author":"Walenkamp","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","article-title":"Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling","volume":"1","author":"Corsello","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fnmol.2020.00087","article-title":"Regeneration of cochlear synapses by systemic administration of a bisphosphonate","volume":"13","author":"Seist","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref_41","first-page":"55704","article-title":"Neonatal murine cochlear explant technique as an in vitro screening tool in hearing research","volume":"8","author":"Landegger","year":"2017","journal-title":"J. Vis. Exp."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5955(85)90006-1","article-title":"Kainic acid selectively alters auditory dendrites connected with cochlear inner hair cells","volume":"18","author":"Pujol","year":"1985","journal-title":"Hear. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e142572","DOI":"10.1172\/jci.insight.142572","article-title":"Trk agonist drugs rescue noise-induced hidden hearing loss","volume":"6","author":"Fernandez","year":"2021","journal-title":"JCI Insight"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: A next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"ref_45","unstructured":"Horizon Pharma USA, Inc. (2023, February 22). Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT01868997."},{"key":"ref_46","unstructured":"Horizon Pharma USA, Inc. (2023, February 22). Treatment of Graves\u2019 Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT03298867."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: An overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_48","unstructured":"United States Food and Drug Administration, and Center for Drug Evaluation and Research (2023, February 22). Application Number: 761143Orig1s000 Summary Review [Teprezza], Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/761143Orig1s000SumR.pdf."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.1712","article-title":"Insulin-like growth factor ligands, receptors, and binding proteins in cancer","volume":"205","author":"Foulstone","year":"2005","journal-title":"J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yoshida, T., and Delafontaine, P. (2020). Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells, 9.","DOI":"10.3390\/cells9091970"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1179\/016164104225013851","article-title":"The multifunctional role of IGF-1 in peripheral nerve regeneration","volume":"26","author":"Rabinovsky","year":"2004","journal-title":"Neurol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","article-title":"Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle","volume":"27","author":"McCullagh","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sanchez-Calderon, H., Rodriguez-de la Rosa, L., Milo, M., Pichel, J.G., Holley, M., and Varela-Nieto, I. (2010). RNA microarray analysis in prenatal mouse cochlea reveals novel IGF-I target genes: Implication of MEF2 and FOXM1 transcription factors. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0008699"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18104","DOI":"10.1523\/JNEUROSCI.3619-11.2011","article-title":"Insulin-like growth factor signaling regulates the timing of sensory cell differentiation in the mouse cochlea","volume":"31","author":"Okano","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1460-9568.2005.04584.x","article-title":"Sensorineural hearing loss in insulin-like growth factor I-null mice: A new model of human deafness","volume":"23","author":"Cediel","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/IOP.0000000000002078","article-title":"Rifle blast exacerbating hearing loss in a patient treated with teprotumumab for thyroid eye disease","volume":"38","author":"Reed","year":"2022","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mlg.0000200791.77819.eb","article-title":"Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel","volume":"116","author":"Iwai","year":"2006","journal-title":"Laryngoscope"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MAO.0b013e31811f40db","article-title":"Novel therapy for hearing loss: Delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel","volume":"28","author":"Lee","year":"2007","journal-title":"Otol. Neurotol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/MAO.0000000000001276","article-title":"Activation of IGF1 signaling in the cochlea induces the transcription of its mediators during the protection of cochlear hair cells against aminoglycoside","volume":"38","author":"Hayashi","year":"2017","journal-title":"Otol. Neurotol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/WNR.0b013e328311ca4b","article-title":"Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury","volume":"19","author":"Fujiwara","year":"2008","journal-title":"Neuroreport"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.heares.2018.07.004","article-title":"Hearing preservation at low frequencies by insulin-like growth factor 1 in a guinea pig model of cochlear implantation","volume":"368","author":"Yamahara","year":"2018","journal-title":"Hear. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0378-5955(94)00194-U","article-title":"Monoclonal antibody induced hearing loss","volume":"83","author":"Nair","year":"1995","journal-title":"Hear. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1749-6632.1997.tb51896.x","article-title":"Human autoantibodies and monoclonal antibody KHRI-3 bind to a phylogenetically conserved inner-ear-supporting cell antigen","volume":"830","author":"Disher","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fneur.2019.01353","article-title":"Intracochlear perfusion of tumor necrosis factor-alpha induces sensorineural hearing loss and synaptic degeneration in guinea pigs","volume":"10","author":"Katsumi","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.heares.2019.01.006","article-title":"The role of monocytes and macrophages in the dynamic permeability of the blood-perilymph barrier","volume":"374","author":"Hirose","year":"2019","journal-title":"Hear. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41598-017-00330-5","article-title":"The blood labyrinthine barrier in the human normal and Meniere\u2019s disease macula utricle","volume":"7","author":"Ishiyama","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/MOO.0000000000000652","article-title":"Insulin-like growth factor 1: Role in the auditory system and therapeutic potential in otology","volume":"28","author":"Gao","year":"2020","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"ref_68","unstructured":"Horizon Pharma USA, Inc. (2023, February 22). Treatment of Graves\u2019 Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Study, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT03461211."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-019-0555-x","article-title":"Drug repurposing for Alzheimer\u2019s disease based on transcriptional profiling of human iPSC-derived cortical neurons","volume":"9","author":"Williams","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/10\/3485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:35:51Z","timestamp":1760124951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/10\/3485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jcm12103485"],"URL":"https:\/\/doi.org\/10.3390\/jcm12103485","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]}}}